+ADw-html xmlns:v+AD0AIg-urn:schemas-microsoft-com:vml+ACI- xmlns:o+AD0AIg-urn:schemas-microsoft-com:office:office+ACI- xmlns:w+AD0AIg-urn:schemas-microsoft-com:office:word+ACI- xmlns:st1+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- xmlns+AD0AIg-http://www.w3.org/TR/REC-html40+ACIAPg- +ADw-head+AD4- +ADw-meta http-equiv+AD0-Content-Type content+AD0AIg-text/html+ADs- charset+AD0-utf-7+ACIAPg- +ADw-meta name+AD0-ProgId content+AD0-Word.Document+AD4- +ADw-meta name+AD0-Generator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-meta name+AD0-Originator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-link rel+AD0-File-List href+AD0AIg-als24378+AF8-files/filelist.xml+ACIAPg- +ADw-link rel+AD0-Edit-Time-Data href+AD0AIg-als24378+AF8-files/editdata.mso+ACIAPg- +ADwAIQ---+AFs-if +ACE-mso+AF0APg- +ADw-style+AD4- v+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- o+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- w+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- .shape +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-title+AD4-Anti-TERE1 antibodies from RDI Division of Fitzgerald Industries Intl+ADw-/title+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-country-region+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-PostalCode+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-State+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-City+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-Street+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-address+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-place+ACI-/+AD4- +ADwAIQ---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:DocumentProperties+AD4- +ADw-o:Author+AD4-Martha Rozynski+ADw-/o:Author+AD4- +ADw-o:LastAuthor+AD4-Martha Rozynski+ADw-/o:LastAuthor+AD4- +ADw-o:Revision+AD4-2+ADw-/o:Revision+AD4- +ADw-o:TotalTime+AD4-0+ADw-/o:TotalTime+AD4- +ADw-o:Created+AD4-2008-05-16T21:09:00Z+ADw-/o:Created+AD4- +ADw-o:LastSaved+AD4-2008-05-16T21:09:00Z+ADw-/o:LastSaved+AD4- +ADw-o:Pages+AD4-1+ADw-/o:Pages+AD4- +ADw-o:Words+AD4-378+ADw-/o:Words+AD4- +ADw-o:Characters+AD4-2157+ADw-/o:Characters+AD4- +ADw-o:Company+AD4-Trinity Biotech USA+ADw-/o:Company+AD4- +ADw-o:Lines+AD4-17+ADw-/o:Lines+AD4- +ADw-o:Paragraphs+AD4-5+ADw-/o:Paragraphs+AD4- +ADw-o:CharactersWithSpaces+AD4-2530+ADw-/o:CharactersWithSpaces+AD4- +ADw-o:Version+AD4-11.9999+ADw-/o:Version+AD4- +ADw-/o:DocumentProperties+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:WordDocument+AD4- +ADw-w:GrammarState+AD4-Clean+ADw-/w:GrammarState+AD4- +ADw-w:ValidateAgainstSchemas/+AD4- +ADw-w:SaveIfXMLInvalid+AD4-false+ADw-/w:SaveIfXMLInvalid+AD4- +ADw-w:IgnoreMixedContent+AD4-false+ADw-/w:IgnoreMixedContent+AD4- +ADw-w:AlwaysShowPlaceholderText+AD4-false+ADw-/w:AlwaysShowPlaceholderText+AD4- +ADw-w:BrowserLevel+AD4-MicrosoftInternetExplorer4+ADw-/w:BrowserLevel+AD4- +ADw-/w:WordDocument+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:LatentStyles DefLockedState+AD0AIg-false+ACI- LatentStyleCount+AD0AIg-156+ACIAPg- +ADw-/w:LatentStyles+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if +ACE-mso+AF0APgA8-object classid+AD0AIg-clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D+ACI- id+AD0-ieooui+AD4APA-/object+AD4- +ADw-style+AD4- st1+AFw-:+ACoAew-behavior:url(+ACM-ieooui) +AH0- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-style+AD4- +ADwAIQ--- /+ACo- Style Definitions +ACo-/ p.MsoNormal, li.MsoNormal, div.MsoNormal +AHs-mso-style-parent:+ACIAIgA7- margin:0in+ADs- margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- p +AHs-font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- span.GramE +AHs-mso-style-name:+ACIAIgA7- mso-gram-e:yes+ADsAfQ- +AEA-page Section1 +AHs-size:8.5in 11.0in+ADs- margin:1.0in 1.25in 1.0in 1.25in+ADs- mso-header-margin:.5in+ADs- mso-footer-margin:.5in+ADs- mso-paper-source:0+ADsAfQ- div.Section1 +AHs-page:Section1+ADsAfQ- --+AD4- +ADw-/style+AD4- +ADwAIQ---+AFs-if gte mso 10+AF0APg- +ADw-style+AD4- /+ACo- Style Definitions +ACo-/ table.MsoNormalTable +AHs-mso-style-name:+ACI-Table Normal+ACIAOw- mso-tstyle-rowband-size:0+ADs- mso-tstyle-colband-size:0+ADs- mso-style-noshow:yes+ADs- mso-style-parent:+ACIAIgA7- mso-padding-alt:0in 5.4pt 0in 5.4pt+ADs- mso-para-margin:0in+ADs- mso-para-margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:10.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-ansi-language:+ACM-0400+ADs- mso-fareast-language:+ACM-0400+ADs- mso-bidi-language:+ACM-0400+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-meta name+AD0-description content+AD0AIg-Anti-TERE1 antibodies from RDI Divison of Fitzgerald Industries Intl.+ACIAPg- +ADw-meta name+AD0-keywords content+AD0AIg-rdi-als24378, tere1, tere 1, bladder cancer,+ACIAPg- +ADwAIQ---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:shapedefaults v:ext+AD0AIg-edit+ACI- spidmax+AD0AIg-2050+ACI-/+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:shapelayout v:ext+AD0AIg-edit+ACIAPg- +ADw-o:idmap v:ext+AD0AIg-edit+ACI- data+AD0AIg-1+ACI-/+AD4- +ADw-/o:shapelayout+AD4APA-/xml+AD4APAAhAFs-endif+AF0---+AD4- +ADw-/head+AD4- +ADw-body lang+AD0-EN-US link+AD0-blue vlink+AD0-blue style+AD0-'tab-interval:.5in'+AD4- +ADw-div class+AD0-Section1+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-rev+ADw-/span+AD4-: +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs-5/16/2008+ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/index.htm+ACIAPg-HOME+ADw-/a+AD4- +ACY-nbsp+ADs- (index page) +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/absort.htm+ACIAPg-Return +ADw-/a+AD4AJg-nbsp+ADs- (alphabetical antibody page) +ADw-/p+AD4- +ADw-p align+AD0-center style+AD0-'text-align:center'+AD4APA-br+AD4- +ADw-b+AD4AJg-nbsp+ADs- ANTIBODIES+ADw-/b+AD4- +ACY-nbsp+ADs- +ADw-/p+AD4- +ADw-p align+AD0-center style+AD0-'text-align:center'+AD4-(+ADw-span class+AD0-GramE+AD4-anti-Human+ADw-/span+AD4- and others as indicated) +ADw-/p+AD4- +ADw-p+AD4-RDI Division of Fitzgerald Industries +ADw-span class+AD0-GramE+AD4-Intl +ACY-nbsp+ADs-offers+ADw-/span+AD4- a wide line of +ACY-nbsp+ADs-antibodies. Since no one antibody works best for all applications (neutralization, blotting, ELISA, etc), we offer many different types of antibodies to help solve this problem. Please inquire for other applications or types of antibodies not listed below. +ADw-/p+AD4- +ADw-div class+AD0-MsoNormal align+AD0-center style+AD0-'text-align:center'+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- align+AD0-center+AD4- +ADw-/div+AD4- +ADw-p class+AD0-MsoNormal+AD4APA-b+AD4-Anti-TERE1 Polyclonal Antibody+ADw-/b+AD4- +ADw-/p+AD4- +ADw-p+AD4-Catalog Number: RDI-ALS24378 +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACQ-346.50/100ug +ADw-/p+AD4- +ADw-p+AD4AJg-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- RDI-ALS24378X +ACY-nbsp+ADs- +ACQ-1875.01/mg +ADw-/p+AD4- +ADw-p+AD4APA-st1:place w:st+AD0AIg-on+ACIAPg-Lot+ADw-/st1:place+AD4- Number: +ADw-/p+AD4- +ADw-p+AD4-Quantity: 100ug in 100ul (1 mg/ml) in PBS containing 0.02+ACU- sodium azide. +ADw-/p+AD4- +ADw-p+AD4-Description: A novel gene designated TERE1, has a significant effect on the growth regulation in bladder cancer. The TERE1 gene maps to a chromosome locus that has been identified by loss of heterozygosity studies as a site of a putative tumor suppressor gene or genes for multiple tumor types including prostate carcinoma. Data suggest that TERE1 may be significant in prostate cancer growth regulation and the down regulation or absence of TERE1 may be an important component of the phenotype of advanced disease. Data also suggest a potential role for this gene product in the progression of bladder cancer. +ADw-/p+AD4- +ADw-p+AD4-Host Species: Rabbit +ADw-/p+AD4- +ADw-p+AD4-Specificity: Reacts with residues 32-45 +AFs-PEQDRLPQRSWRQK+AF0- of the 37 kDa human TERE1 protein. This sequence is 85+ACU- identical in mouse and rat. +ADw-/p+AD4- +ADw-p+AD4-Applications: Western blot - Use at 1:500 +ADw-span class+AD0-GramE+AD4-dilution+ADw-/span+AD4-. However, the investigator should determine the optimal dilution for a specific application such as immunohistochemistry. +ADw-/p+AD4- +ADw-p+AD4-Format: Affinity purified IgG +ADw-/p+AD4- +ADw-p+AD4-Storage: Maintain at 8+ALA-C for 3 months or at -20+ALA-C for longer periods. +ADw-span class+AD0-GramE+AD4-Stable for 1 year.+ADw-/span+AD4- Avoid repeated freeze-thaw cycles. +ADw-/p+AD4- +ADw-p+AD4-References: McGarvey T.W. et al. Oncogene. 2001 Mar 1+ADw-span class+AD0-GramE+AD4AOw-20+ADw-/span+AD4-(9):1042-51. +ADw-/p+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-McGarvey T.W. et al. Prostate.+ADw-/span+AD4- 2003 Feb 1+ADw-span class+AD0-GramE+AD4AOw-54+ADw-/span+AD4-(2):144-55. +ADw-/p+AD4- +ADw-p+AD4-For In Vitro research use only+ADs- not for use in or on humans or animals-not for use in diagnostics +ADw-/p+AD4- +ADw-div class+AD0-MsoNormal align+AD0-center style+AD0-'text-align:center'+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- align+AD0-center+AD4- +ADw-/div+AD4- +ADw-p+AD4-RDI Division of Fitzgerald Industries Intl +ADw-/p+AD4- +ADw-p+AD4APA-st1:Street w:st+AD0AIg-on+ACIAPgA8-st1:address w:st+AD0AIg-on+ACIAPg-34 Junction Square+ADw-/st1:address+AD4APA-/st1:Street+AD4- Drive +ADw-/p+AD4- +ADw-p+AD4APA-st1:place w:st+AD0AIg-on+ACIAPgA8-st1:City w:st+AD0AIg-on+ACIAPg-Concord+ADw-/st1:City+AD4- +ADw-st1:State w:st+AD0AIg-on+ACIAPg-MA+ADw-/st1:State+AD4- +ADw-st1:PostalCode w:st+AD0AIg-on+ACIAPg-01742+ADw-/st1:PostalCode+AD4APA-/st1:place+AD4--3049 +ADw-/p+AD4- +ADw-p+AD4APA-st1:country-region w:st+AD0AIg-on+ACIAPgA8-st1:place w:st+AD0AIg-on+ACIAPg-USA+ADw-/st1:place+AD4APA-/st1:country-region+AD4- +ADw-/p+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-phone+ADw-/span+AD4- (978) 371-6446 or (800) 370-2222 +ADw-/p+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-fax+ADw-/span+AD4- +ACY-nbsp+ADs- +ACY-nbsp+ADs- (978) 371-2266 +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-mailto:antibodies+AEA-fitzgerald-fii.com+ACIAPg-EMAIL:antibodies+AEA-fitzgerald-fii.com+ADw-/a+AD4- +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/absort.htm+ACIAPg-Return +ADw-/a+AD4AJg-nbsp+ADs- (alphabetical antibody page) +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/terms.htm+ACIAPg-Ordering +ADw-/a+AD4-terms +ADw-/p+AD4- +ADw-/div+AD4- +ADw-/body+AD4- +ADw-/html+AD4-